|

IRIS- DESyne X2 in the IRIS-DES Registry

RECRUITINGSponsored by Seung-Jung Park
Actively Recruiting
SponsorSeung-Jung Park
Started2018-11-28
Est. completion2026-12-31
Eligibility
Age19 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03588481

Summary

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 19 and more
* Intervention with DeSyne X2 drug-eluting coronary stent
* Agreed with written informed consent form

Exclusion Criteria:

* Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
* Life expectancy of 1year and under
* Cardiac shock

Conditions4

Coronary DiseaseCoronary OcclusionCoronary StenosisHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.